After Pfizer and Moderna, Covishield-maker Serum Institute of India (SII) has asked for indemnity from liability, according to sources. All vaccine makers, whether Indian or foreign, should be granted...
from NDTV News - Special https://ift.tt/3pjasEe
via IFTTT
Post Top Ad
Wednesday, 2 June 2021
Serum Institute Seeks Indemnity, Says "Same Rules For All": Sources
Tags
# IFTTT
# NDTV News - Special
Share This
About Unknown
NDTV News - Special
Labels:
IFTTT,
NDTV News - Special
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment